Cirugía en medicina general: manual de enfermedades quirúrgicas

143 Capítulo 14 / Cáncer de Esófago Santiago, Chile: Universidad de Chile. Burdiles, P., Csendes, A., Braghetto, I.,y Korn, O. (2007). Displasia de alto grado en el esófago de Barrett. Parte II: Alternativas de tratamiento. Revista Chilena de Cirugía, 59(3), 233-243. Bytzer, P., Christensen, P., Damkier, P., Vinding, K., y Seersholm, N. (1999). Adenocarcinoma of the esophagus and Barrett’s esophagus: a population-based study. American Journal of Gastroenterology, 94(1), 86-91. Bytzer, P., Christensen, P., Damkier, P., Vinding, K., y Seersholm, N. (1999). Adenocarcinoma of the esophagus and Barrett’s esophagus: a population-based study. American Journal of Gastroenterology, 94(1), 86-91. Cameron, A., Lomboy, C., Pera, M., y Carpenter, H. (1995). Adenocarcinoma of the esophagogastric junction and Barrett’s esophagus. Gastroenterology, 109(5), 1541-1546. Estay, R. (2013). Cáncer de esófago. En J. Weitz, Z. Berger, S. Sabah, y H. Silva, Diagnóstico y tratamiento de las enfermedades digestivas (pp. 111-121). Santiago, Chile: IKU. Gammon, M.D., Schoenberg, J.B., Ahsan, H., Risch, H.A., Vaughan, T.L., Chow, W.H., Rotterdam, H., West, A.B., Dubrow, R., Stanford, J.L., Mayne, S.T., Farrow, D.C., Niwa, S., Blot, W.J., y Fraumeni, J.F. Jr. (1997). Tobacco, Alcohol, and Socioeconomic Status and Adenocarcinomas of the Esophagus and Gastric Cardia. Journal of the National Cancer Institute, 89(17), 1277- 1284. Gholipour, C., Shalchi, R., y Abbasi, M. (2008). A histopathological study of esophageal cancer on the western side of the Caspian littoral from 1994 to 2003. Diseases of the Esophagus, 21(4),322.327. He, Z., Zhao, Y., Guo, C., Liu, Y., Sun, M., Liu, F., Wang, X., Guo, F., Chen, K., Gao, L., Ning, T., Pan, Y., Li, Y., Zhang, S., Lu, C., Wang, Z., Cai, H., y Ke, Y. (2010). Prevalence and risk factors for esophageal squamous cell cancer and precursor lesions in Anyang, China: a population-based endoscopic survey. British Journal of Cancer, 103(7),1085-1088. Jemal, A., Bray, F., Center, M.M., Ferlay, J., Ward, E., y Forman, D. (2011). Global cancer statistics. CA: a Cancer Journal for Clinicians, 61(2), 69-90. Kim, T., Kim , H., y Kim, M. (2009). Multimodality Assessment of Esophageal Cancer: Preoperative Staging and Monitoring of Response to Therapy. Radiographics, 29(2), 403-421. Lam, K., He, D., Zhang, D., Ngan, H., Wan, T., y Tsao, S. (1997). Presence of human papillomavirus in esophageal squamous cell carcinomas of Hong Kong Chinese and its relationship with p53 gene mutation. Human Pathology, 28(6), 657-663. Lauby-Secretan, B., Scoccianti, C., Loomis, D., Grosse, Y., Bianchini, F., y Straif, K. (2016). Body Fatness and Cancer- Viewpoint of the IARC Working Group. The New England Journal of Medicine, 75(8), 794-798. Lee, W.C., Lee, T.H., Jang, J.Y., Lee, J.S., Cho, J.Y., Lee, J.S., Jeon, S.R., Kim, H.G., Kim, J.O., y Cho, Y.K. (2015). Staging accuracy of endoscopic ultrasound performed by nonexpert endosonographers in patients with resectable esophageal squamous cell carcinoma: is it possible? Diseases of the Esophagus, 28(6), 574-578. MINSAL. (2016). Estrategia Nacional de Cáncer. Santiago, Chile. Pohl, H., Sirovich, B., y Welch, H. (2010). Esophageal adenocarcinoma incidence: are we reaching the peak? Cancer Epidemiology, Biomarkers and Prevention, 19(6), 1468-1470. Roco, Á., Quiñones, L., Acevedo, C., y Zagmutt, O. (2013). Situación del cáncer en Chile 2000 – 2010. Cuadernos Médicos Sociales, 53(2), 83-94. Rubenstein, J., y Taylor, J. (2010). Meta-analysis: the association of oesophageal adenocarcinoma with symptoms of gastro-oesophageal reflux. Alimentary Pharmacology ant Theraoeutics, 32(10), 1222-1227. Stevens, H.P., Kelsell, D.P., Bryant, S.P., Bishop, D.T., Spurr, .N.K, Weissenbach, J., Marger, D., Marger, R.S., y Leigh, I.M. (1996). Linkage of an American pedigree with palmoplantar keratoderma and malignancy (palmoplantar ectodermal dysplasia type III) to 17q24. Literature survey and proposed updated classification of the keratoderma. Archives of Dermatology, 132(6), 640-651. Torre, L., Bray, F., Siegel, R., Ferlay, J., Lortet-Tieulent, J., y Jemal , A. (2012). Global cancer statistics. CA: a Cancer Journal for Clinicians, 65(2), 87-108. Urschel, J.,y Vasan, H. (2003). A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. American Journal of Surgery, 185(6), 538-543. Valladares, H. (2015). Tratamiento paliativo del cáncer esofágico y de la unión gastro-esofágica mediante colocación de prótesis transtumoral por vía endoscópica. Revista Chilena de Cirugía, 67(4), 360-370. Yendamuri, S., Swisher, S.G., Correa, A.M., Hofstetter, W., Ajani, J.A., Francis, A., Maru, D., Mehran, R.J., Rice, D.C., Roth, J.A., Walsh, G.L., y Vaporciyan, A.A.. (2009). Esophageal tumor length is independently associated with long-term survival. Cancer, 115(3), 508-516. Zhigang, L., y Rice, T. (2012). Diagnosis and Staging of Cancer of the Esophagus and Esophagogastric Junction. The Surgeon Clinics of North America 92(5), 1105–1126.